Get the Stockscreener App
43.32
1.48%
-0.6498
After Hours:
43.35
0.0262
+0.06%
Global X Genomics Biotechnology Etf stock is traded at $43.32, with a volume of 15,009.
It is down -1.48% in the last 24 hours and down -9.38% over the past month.
See More
Previous Close:
$43.97
Open:
$43.22
24h Volume:
15,009
Relative Volume:
1.53
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.11%
1M Performance:
-9.38%
6M Performance:
+14.40%
1Y Performance:
+27.87%
1-Day Range:
$43.22
$43.96
1-Week Range:
$42.14
$44.15
52-Week Range:
$27.20
$51.42
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Name
Global X Genomics Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Compare GNOM vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
43.32 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
319.55 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
State Street Spdr S P 500 Etf Trust
|
645.09 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
648.01 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
261.74 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
573.79 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Stock (GNOM) Latest News
IBBQ, GNOM, BIB: Biotech ETFs Offer Exposure to Healthcare Startup Companies - TipRanks
Stock List: Research Stocks from Around the World - GuruFocus
Biotech Stocks and Longevity Investing: Trends To Track - Newsweek
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing - AOL.com
Biotech stocks and longevity investing: Trends to track - Laclede County Record
Avoiding Lag: Real-Time Signals in (GNOM) Movement - Stock Traders Daily
Global X Genomics & Biotechnology ETF Index OverviewStock Price, Quote and News - marketscreener.com
Biotech Stocks & Longevity Investing: Trends to Track - The Motley Fool
GNOM Technical Analysis & Stock Price Forecast - Intellectia AI
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - sharewise.com
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom - Bitget
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - The Globe and Mail
Global X Genomics & Biotechnology ETF: Performance & Quotes, GNOM.EU Stock Price on Nasdaq Exchange - marketscreener.com
Discipline and Rules-Based Execution in GNOM Response - Stock Traders Daily
GNOM, CANC, IBB: Use Targeted Healthcare ETFs to Build Wealth - TipRanks
GNOM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Top Canadian Genetics Stocks of 2026 - The Motley Fool Canada
Behavioral Patterns of GNOM and Institutional Flows - Stock Traders Daily
EDGAR Filing Documents for 0001135428-20-000018 - SEC.gov
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026 - TipRanks
How to Buy Moderna Stock (MRNA) in 2026 - The Motley Fool
Top ETFs Tracking CRISPR Gene Editing for 2026 - The Motley Fool
The long game: ASX ETFs to target amidst an ageing population - MSN
(GNOM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money
5 Small-cap Biotech ETFs to Watch - Nasdaq
Entravision Communications (NYSE:EVC) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Lakeland Financial (NASDAQ:LKFN) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
German American Bancorp (NASDAQ:GABC) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
AlTi Global (NASDAQ:ALTI) Shares Pass Above Two Hundred Day Moving Average – What’s Next? - Defense World
Demand Brands (OTCMKTS:DMAN) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Mercury General (NYSE:MCY) Shares Pass Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Riverview Bancorp (NASDAQ:RVSB) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
VirnetX (NYSE:VHC) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
IBBQ, GNOM, BIB: Gain Exposure to Healthcare Startups with Biotech ETFs - TipRanks
Chimerix Shares Approach Peak on Partner’s Rosy Forecast - AD HOC NEWS
Best Biotech ETFs to Buy in 2026 - The Motley Fool
How (GNOM) Movements Inform Risk Allocation Models - Stock Traders Daily
Trading Systems Reacting to (GNOM) Volatility - Stock Traders Daily
Moderna (MRNA) Stock Surge Boosts ETFs with High Exposure - GuruFocus
Moderna’s rally ripples through biotech and health care ETFs - Seeking Alpha
The Next Big Theme: January 2026 - Global X ETFs
Short Interest in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Expands By 23.3% - Defense World
How Global X Genomics & Biotechnology Etf (GNOM) Affects Rotational Strategy Timing - Stock Traders Daily
FengHe Fund Management Pte. Ltd. Invests $36.48 Million in Ciena Corporation $CIEN - Defense World
Invesco BulletShares 2025 Corporate Bond ETF $BSCP Shares Bought by Farnam Financial LLC - Defense World
Schwab US Large-Cap ETF $SCHX is Farnam Financial LLC’s Largest Position - Defense World
FengHe Fund Management Pte. Ltd. Invests $49.61 Million in Analog Devices, Inc. $ADI - Defense World
Clarity Wealth Advisors LLC Has $9.09 Million Stock Position in JPMorgan Core Plus Bond ETF $JCPB - Defense World
Vanguard Small-Cap ETF $VB Shares Acquired by Farnam Financial LLC - Defense World
Vanguard FTSE Developed Markets ETF $VEA Shares Bought by Farnam Financial LLC - Defense World
Global X Genomics Biotechnology Etf Stock (GNOM) Financials Data
There is no financial data for Global X Genomics Biotechnology Etf (GNOM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):